1. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy. (3rd August 2019) Authors: Terpos, Evangelos; Jamotte, Aurelien; Christodoulopoulou, Alexandra; Campioni, Marco; Bhowmik, Debajyoti; Kennedy, Lisa; Willenbacher, Wolfgang Journal: Journal of medical economics Issue: Volume 22:Number 8(2019) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials. Issue 1 (2nd January 2020) Authors: Weisel, Katja; Majer, Istvan; DeCosta, Lucy; Oriol, Albert; Goldschmidt, Hartmut; Ludwig, Heinz; Campioni, Marco; Szabo, Zsolt; Dimopoulos, Meletios Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective. (1st November 2016) Authors: Jakubowiak, Andrzej J.; Campioni, Marco; Benedict, Ágnes; Houisse, Ivan; Tichy, Eszter; Giannopoulou, Andromachi; Aggarwal, Sanjay K.; Barber, Beth L.; Panjabi, Sumeet Journal: Journal of medical economics Issue: Volume 19:Number 11(2016) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States. Issue 12 (2nd December 2017) Authors: Jakubowiak, Andrzej J.; Houisse, Ivan; Májer, István; Benedict, Ágnes; Campioni, Marco; Panjabi, Sumeet; Ailawadhi, Sikander Journal: Expert review of hematology Issue: Volume 10:Issue 12(2017) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States. Issue 6 (2nd June 2020) Authors: Kumar, Shaji K.; Majer, Istvan; Panjabi, Sumeet; Medhekar, Rohan; Campioni, Marco; Dimopoulos, Meletios A. Journal: Expert review of hematology Issue: Volume 13:Issue 6(2020) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States. Issue 6 (2nd June 2020) Authors: Kumar, Shaji K.; Majer, Istvan; Panjabi, Sumeet; Medhekar, Rohan; Campioni, Marco; Dimopoulos, Meletios A. Journal: Expert review of hematology Issue: Volume 13:Issue 6(2020) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making. Issue 1 (January 2019) Authors: Gonzalez-McQuire, Sebastian; Dimopoulos, Meletios-Athanassios; Weisel, Katja; Bouwmeester, Walter; Hájek, Roman; Campioni, Marco; Bennison, Craig; Xu, Weiwei; Pantiri, Krystallia; Hensen, Marja; Terpos, Evangelos; Knop, Stefan Journal: MDM policy & practice Issue: Volume 4:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy. (4th May 2018) Authors: Gonzalez-McQuire, Sebastian; Yong, Kwee; Leleu, Henri; Mennini, Francesco S.; Flinois, Alain; Gazzola, Carlotta; Schoen, Paul; Campioni, Marco; DeCosta, Lucy; Fink, Leah Journal: Journal of medical economics Issue: Volume 21:Number 5(2018) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review. Issue 7 (14th July 2020) Authors: Hájek, Roman; Gonzalez-McQuire, Sebastian; Szabo, Zsolt; Delforge, Michel; DeCosta, Lucy; Raab, Marc S; Bouwmeester, Walter; Campioni, Marco; Briggs, Andrew Journal: BMJ open Issue: Volume 10:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed‐effects analysis. (26th June 2014) Authors: Zühlsdorf, Michael; Bhattaram, Venkatesh Atul; Campioni, Marco; Krösser, Sonja; Derendorf, Hartmut; Kovar, Andreas Journal: Journal of clinical pharmacology Issue: Volume 54:Number 12(2014:Dec.) Page Start: 1391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗